Ancora Advisors’s St Jude Medical STJ Stock Holding History

Ancora Advisors’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-21,000	Closed	-$1.68M	–	1250
2016 Q4	$1.68M	Hold	21,000	–	–	0.12%	206
2016 Q3	$1.68M	Sell	21,000 -5,000	-19%	-$404K	0.17%	162
2016 Q2	$2.03M	Buy	+26,000	New	+$1.85M	0.24%	119

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Ancora Advisors's STJ Position: Q1 2017 in Review

Ancora Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 21,000 shares — an estimated $1.68M sold.

Ancora Advisors first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $2.03M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Ancora Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Ancora Advisors sold 21,000 St Jude Medical shares in Q1 2017, an estimated $1.68M.
Ancora Advisors first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
Ancora Advisors's St Jude Medical position peaked at $2.03M in Q2 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Ancora Advisors's 13F filing for Q1 2017, filed 15 May 2017.